Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Cantor Fitzgerald
Federal Trade Commission
Julphar
Teva
Chubb
AstraZeneca
Medtronic

Generated: October 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,638,522

« Back to Dashboard

Title:Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino] benzonitrile
Abstract: The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino- ]benzonitrile and to processes for their preparation.
Inventor(s): Guillemont; Jerome Emile Georges (Ande, FR), Stevens; Paul Theodoor Agnes (Turnhout, BE), Copmans; Alex Herman (Lille, BE), Peeters; Jozef (Beerse, BE), Stappers; Alfred Elisabeth (Oud-Turnhout, BE), Vandecruys; Roger Petrus Gerebern (Westerlo, BE), Stoffels; Paul (Hoogstraten, BE)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Filing Date:Sep 02, 2005
Application Number:11/219,163
Claims:1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula (I-a) ##STR00004## wherein said pharmaceutically acceptable carrier comprises: from 0.01 to 5% of said pharmaceutical composition of a wetting agent; from 40 to 92% of said pharmaceutical composition of a diluent; from 0 to 10% of said pharmaceutical composition of a polymer; from 2 to 10% of said pharmaceutical composition of a disintegrant; from 0.1 to 5% of said pharmaceutical composition of a glidant; and from 0.1 to 1.5% of said pharmaceutical composition of a lubricant; and wherein said compound of formula (I-a) is present in said pharmaceutical composition at from 5-50% of said pharmaceutical composition.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Express Scripts
Medtronic
Moodys
Accenture
Teva
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.